States Oppose Term In Sandoz Price-Fixing Deal With Fla.

By Jared Foretek · March 18, 2025, 5:32 PM EDT

State enforcers still locked in price-fixing litigation against generic-drug maker Sandoz are raising objections to a cap on what they could win through settlements in Florida's recent agreement with the company,...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Notice

Case Information

Case Title

Connecticut et al v. Aurobindo Pharma USA, Inc. et al

Case Number

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

December 15, 2016

Recent Articles By Jared

March 13, 2025
PBMs Tell FTC 5-Month Delay Too Long For In-House Insulin Trial
February 27, 2025
FTC Asks To Delay In-House PBM Insulin Case
February 26, 2025
CVS Ordered To Comply With FTC's PBM Subpoena
January 24, 2025
Biotech Co. Defends Antitrust Counterclaims Against Rival
January 16, 2025
Initial Green Light Given to UnitedHealth's Deal In TCPA Suit
January 14, 2025
FTC Issues Second Report On PBMs, Expanding Study Scope
December 17, 2024
House GOP Asks CVS How Its PBM Treats Smaller Pharmacies
November 14, 2024
Emergency Medical Providers Oppose $2.8B BCBS Deal
October 28, 2024
Hospital Wants NC County's 'Monopoly' Suit Tossed
October 09, 2024
CVS, United Health Seek Removal Of FTC's Khan In PBM Case